We are live on ! Find out more
GEHC icon

GE HealthCare

1,272 hedge funds and large institutions have $35.6B invested in GE HealthCare in 2024 Q3 according to their latest regulatory filings, with 155 funds opening new positions, 473 increasing their positions, 409 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more first-time investments, than exits

New positions opened: 155 | Existing positions closed: 81

22% more capital invested

Capital invested by funds: $29.1B → $35.6B (+$6.49B)

22% more funds holding in top 10

Funds holding in top 10: 911 (+2)

16% more repeat investments, than reductions

Existing positions increased: 473 | Existing positions reduced: 409

12% more call options, than puts

Call options by funds: $579M | Put options by funds: $518M

5% more funds holding

Funds holding: 1,2131,272 (+59)

1.44% more ownership

Funds ownership: 81.76%83.2% (+1.4%)

Holders
1,272
Holders Change
+59
Holders Change %
+4.86%
% of All Funds
18.27%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.16%
New
155
Increased
473
Reduced
409
Closed
81
Calls
$579M
Puts
$518M
Net Calls
+$60.8M
Net Calls Change
-$66M
Name Holding Trade Value Shares
Change
Change in
Stake
II
201
IFM Investors
Australia
$8.57M +$21.6K +257 +0.3%
Skandinaviska Enskilda Banken (SEB)
202
Skandinaviska Enskilda Banken (SEB)
Sweden
$8.38M +$4.2K +50 +0.1%
AB
203
Amalgamated Bank
New York
$8.18M +$147K +1,757 +2%
RJFSA
204
Raymond James Financial Services Advisors
Florida
$7.92M +$1.47M +17,541 +26%
IWA
205
IBEX Wealth Advisors
New Jersey
$7.84M +$15.4M +183,203 +3,997%
CJL
206
Cyrus J. Lawrence
New York
$7.82M +$47.4K +565 +0.7%
MGP
207
M&G plc
United Kingdom
$7.81M +$308K +3,673 +5%
CIM
208
Chapman Investment Management
California
$7.77M -$50.6K -603 -0.7%
HC
209
Henshaw Capital
Massachusetts
$7.76M
Daiwa Securities Group
210
Daiwa Securities Group
Japan
$7.73M +$746K +8,890 +12%
FAF
211
Fjarde Ap-fonden
Sweden
$7.69M +$6.88M +81,955 New
Truist Financial
212
Truist Financial
North Carolina
$7.62M -$295K -3,514 -4%
FWC
213
First Washington Corp
Washington
$7.58M -$698K -8,313 -9%
Mackenzie Financial
214
Mackenzie Financial
Ontario, Canada
$7.51M +$360K +4,287 +6%
LP
215
LMR Partners
United Kingdom
$7.39M +$6.61M +78,711 New
SDIC
216
South Dakota Investment Council
South Dakota
$7.32M
Mariner
217
Mariner
Kansas
$7.3M +$1.69M +20,096 +35%
Cetera Investment Advisers
218
Cetera Investment Advisers
Illinois
$7.25M +$301K +3,587 +5%
Nisa Investment Advisors
219
Nisa Investment Advisors
Missouri
$7.17M +$161K +1,920 +3%
RWP
220
RWA Wealth Partners
Massachusetts
$7.04M +$5.9M +70,247 +1,463%
MS
221
Maven Securities
Jersey
$7.04M +$6.3M +75,024 New
SCM
222
Suvretta Capital Management
New York
$7.04M
Rockefeller Capital Management
223
Rockefeller Capital Management
New York
$7.04M -$217K -2,588 -3%
AAM
224
Azzad Asset Management
Virginia
$7.03M -$29K -346 -0.5%
WTC
225
WhitTier Trust Company
Nevada
$6.96M +$158K +1,879 +3%

GEHC Hedge Fund Activity: Q3 2024 in Review

1,272 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in GE HealthCare (GEHC) for Q3 2024, worth a combined $35.6B — up 22% from $29.1B a quarter earlier.

Buyers outnumbered sellers: 155 funds opened new GEHC positions and 81 closed out — a net gain of 74 holders — while 473 added to existing stakes and 409 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $342M. The largest seller was General Electric, cutting an estimated $1.45B.

  • 1,272 institutional investors held GE HealthCare (GEHC) as of Q3 2024, up from 1,213 in Q2 2024.
  • Funds reported $35.6B of GE HealthCare stock for Q3 2024, up 22% quarter-over-quarter.
  • 155 funds opened new GE HealthCare positions in Q3 2024 and 81 closed out, a net change of +74 holders.
  • The largest GE HealthCare buyer in Q3 2024 was Capital Research Global Investors, an estimated $342M added.
  • The largest GE HealthCare seller in Q3 2024 was General Electric, an estimated $1.45B sold.

Based on aggregated 13F filings for Q3 2024.